Joshua Blume

1PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 02, 2023
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.

Joshua Blume, Luisa Claus, Tamara Isermann

Pageof 1

Frequent Collaborators

1 joint publications

Luisa Claus

1 joint publications

Tamara Isermann

1 joint publications

Antje Dickmanns

1 joint publications

Lena-Christin Conradi